This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Krimsky, S. Articles by Weissman, R. Search for Related Content Social Bookmarking                         What's this?

Academic-Corporate Ties in Biotechnology: A Quantitative Study

Tufts University

James G. Ennis

Tufts University

Robert Weissman

Multinational Monitor

The rapid commercialization of applied genetics in the mtd-1970s, accompanied by a sudden rise in academic-corporate partnerships, raised questions about the impacts these linkages have had on the social and professional norms of scientists. The extent and pattern of faculty tnvolvement in commercialization of biological research is largely an unexplored area. This article provcdes a quantitative assessment of the linkages between biology faculty in American uncverscties and the newly formed biotechnology industry. The results of thes study, covering the period 1985-88, show that academic scientists responded en masse to participating in the commercialization of genetecs research by estabhshmg formal associations with many of the new biotechnology compances. A data base consisting of 889 U.S. and Canadian biotechnology companies and 832 sccentcsts who had formal ties to them was developed over a four-year period. The patterns of academic-corporate Icnkages are revealed by institution. Three universities with the most commercially active faculty are Harvard, Stanford, and MIT. Of the 359 bcomedeca! scientists and geneteccsts who were members of the Nateonal Academy of Sceences (en 1988), at minimum, 37% had formal ties with the biotechnology industry.

Science, Technology & Human Values, Vol. 16, No. 3, 275-287 (1991)
DOI: 10.1177/016224399101600301


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. M. Hedgecoe Terminology and the Construction of Scientific Disciplines: The Case of Pharmacogenomics Science Technology Human Values, October 1, 2003; 28(4): 513 - 537. [Abstract] [PDF]

				M. M. E. Johns, M. Barnes, and P. S. Florencio Restoring Balance to Industry-Academia Relationships in an Era of Institutional Financial Conflicts of Interest: Promoting Research While Maintaining Trust JAMA, February 12, 2003; 289(6): 741 - 746. [Abstract] [Full Text] [PDF]

				J. E. Bekelman, Y. Li, and C. P. Gross Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review JAMA, January 22, 2003; 289(4): 454 - 465. [Abstract] [Full Text] [PDF]

				D. L. Kleinman Untangling Context: Understanding a University Laboratory in the Commercial World Science Technology Human Values, July 1, 1998; 23(3): 285 - 314. [Abstract] [PDF]

				K. Packer and A. Webster Patenting Culture in Science: Reinventing the Scientific Wheel of Credibility Science Technology Human Values, October 1, 1996; 21(4): 427 - 453. [Abstract] [PDF]

				I. Rabino How European and U.S. Genetic Engineering Scientists View the Impact of Public Attention on Their Field: A Comparison Science Technology Human Values, January 1, 1994; 19(1): 23 - 46. [Abstract] [PDF]

				D. Blumenthal Academic-Industry Relationships in the Life Sciences: Extent, Consequences, and Management JAMA, December 16, 1992; 268(23): 3344 - 3349. [Abstract] [PDF]